PCN181 - COST-UTILITY ANALYSIS OF ADJUVANT PERTUZUMAB-BASED REGIMEN IN WOMEN WITH HER2-POSITIVE BREAST CANCER IN ITALY

Oct 1, 2018, 00:00 AM

10.1016/j.jval.2018.09.264

https://www.valueinhealthjournal.com/article/S1098-3015(18)33564-2/fulltext

Section Title :

Section Order : 2008

First Page :

https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33564-2&doi=10.1016/j.jval.2018.09.264

HEOR Topics :

Tags :

Regions :